Assignee
XOMA US LLC
US·14 granted patents·10 pending applications·63 citations·filing 1999–2025
Top patents by PatentIndex Score
24 records- 0186US11261247B2ModulatorsXOMA US LLC·Filed 2018·Granted Mar 1, 2022·2 cites·16 claims
- 0286US2026070972A1ModulatorsXOMA US LLC·Filed 2025·Application pending·0 cites
- 0384US6242219B1Methods for recombinant peptide productionXOMA US LLC·Filed 1999·Granted Jun 5, 2001·38 cites·16 claims
- 0481US9139646B2Methods for the treatment of uveitis with IL-1β binding antibodiesXOMA US LLC·Filed 2013·Granted Sep 22, 2015·8 cites·73 claims
- 0580US12371488B2ModulatorsXOMA US LLC·Filed 2022·Granted Jul 29, 2025·0 cites·13 claims
- 0680US10253101B2Antibody fragments against the insulin receptor and uses thereof to treat hypoglycemiaXOMA US LLC·Filed 2016·Granted Apr 9, 2019·2 cites·33 claims
- 0778US9725510B2ModulatorsXOMA (US) LLC·Filed 2014·Granted Aug 8, 2017·1 cites·20 claims
- 0877US10611832B2Cardiovascular related uses of IL-1β antibodies and binding fragments thereofXOMA US LLC·Filed 2017·Granted Apr 7, 2020·1 cites·48 claims
- 0975US10858428B2Antibodies that bind interleukin-2 and uses thereofXOMA US LLC·Filed 2017·Granted Dec 8, 2020·2 cites·31 claims
- 1073US9163082B2Methods for the treatment of IL-1β related diseasesXOMA US LLC·Filed 2013·Granted Oct 20, 2015·1 cites·51 claims
- 1173US2024158535A1Parathyroid hormone receptor 1(pth1r) antibodies and uses thereofXOMA US LLC·Filed 2023·Application pending·0 cites
- 1271US10519250B2Parathyroid hormone receptor 1 (PTH1R) antibodies and uses thereofXOMA US LLC·Filed 2017·Granted Dec 31, 2019·1 cites·34 claims
- 1370US11787876B2Parathyroid hormone receptor 1 (PTH1R) antibodies and uses thereofXOMA US LLC·Filed 2019·Granted Oct 17, 2023·0 cites·24 claims
- 1469US2023372306A1Compositions and methods for delaying the incidence of laborXOMA US LLC·Filed 2022·Application pending·0 cites
- 1566US10711067B2Treatment of post-prandial hyperinsulinemia and hypoglycemia after bariatric surgeryXOMA US LLC·Filed 2016·Granted Jul 14, 2020·1 cites·24 claims
- 1666US2021032326A1Methods for the treatment of goutXOMA US LLC·Filed 2020·Application pending·0 cites
- 1764US6670327B1Therapeutic uses of BPI protein products in humans with otitis media with effusionXOMA US LLC·Filed 2000·Granted Dec 30, 2003·6 cites·6 claims
- 1862US12234285B2Antibodies that bind interleukin-2 and uses thereofXOMA US LLC·Filed 2020·Granted Feb 25, 2025·0 cites·14 claims
- 1958US2014370002A1Methods for the treatment of goutXOMA US LLC·Filed 2013·Application pending·0 cites
- 2058US2024024294A1Compositions and methods for the treatment or prevention of preterm laborXOMA US LLC·Filed 2021·Application pending·0 cites
- 2157US2021009679A1Cardiovascular related uses of il-1beta antibodies and binding fragments thereofXOMA US LLC·Filed 2020·Application pending·0 cites
- 2254US2017355764A1Methods for the treatment of goutXOMA (US) LLC·Filed 2017·Application pending·0 cites
- 2351US2018251562A1Antibody Fragments Against the Insulin Receptor and Uses Thereof to Treat HypoglycemiaXOMA US LLC·Filed 2018·Application pending·0 cites
- 2444US2015017157A1Methods for treating acneXOMA US LLC·Filed 2012·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →